Search Results - "Fujihara, Kazuo"

Neuromyelitis optica spectrum disorders: still evolving and broadening by Fujihara, Kazuo

“…The diagnostic criteria of neuromyelitis optica spectrum disorders (NMOSD) has been revised in the past 20 years and pathological and therapeutic data have…”
Get full text

MOG-antibody-associated disease is different from MS and NMOSD and should be classified as a distinct disease entity – Commentary by Fujihara, Kazuo

Get full text

Neuromyelitis optica and astrocytic damage in its pathogenesis by Fujihara, Kazuo

“…Abstract Neuromyelitis optica (NMO) is characterized by severe optic neuritis and longitudinally extended, transverse myelitis. There have been long…”
Get full text

Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder by Yamamura, Takashi, Kleiter, Ingo, Fujihara, Kazuo, Palace, Jacqueline, Greenberg, Benjamin, Zakrzewska-Pniewska, Beata, Patti, Francesco, Tsai, Ching-Piao, Saiz, Albert, Yamazaki, Hayato, Kawata, Yuichi, Wright, Padraig, De Seze, Jerome

“…Relapse of neuromyelitis optica spectrum disorder occurred in 20% of patients who received satralizumab, a subcutaneous anti–interleukin-6 antibody, as…”
Get full text

Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide by Hor, Jyh Yung, Fujihara, Kazuo

“…Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is an inflammatory demyelinating disease of the central nervous system (CNS) with…”
Get full text

Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder by Pittock, Sean J, Berthele, Achim, Fujihara, Kazuo, Kim, Ho Jin, Levy, Michael, Palace, Jacqueline, Nakashima, Ichiro, Terzi, Murat, Totolyan, Natalia, Viswanathan, Shanthi, Wang, Kai-Chen, Pace, Amy, Fujita, Kenji P, Armstrong, Róisín, Wingerchuk, Dean M

“…Neuromyelitis optica spectrum disorder is a relapsing inflammatory disorder of the central nervous system. Two thirds of patients have antibodies against…”
Get full text

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria by Thompson, Alan J, Banwell, Brenda L, Barkhof, Frederik, Carroll, William M, Coetzee, Timothy, Comi, Giancarlo, Correale, Jorge, Fazekas, Franz, Filippi, Massimo, Freedman, Mark S, Fujihara, Kazuo, Galetta, Steven L, Hartung, Hans Peter, Kappos, Ludwig, Lublin, Fred D, Marrie, Ruth Ann, Miller, Aaron E, Miller, David H, Montalban, Xavier, Mowry, Ellen M, Sorensen, Per Soelberg, Tintoré, Mar, Traboulsee, Anthony L, Trojano, Maria, Uitdehaag, Bernard M J, Vukusic, Sandra, Waubant, Emmanuelle, Weinshenker, Brian G, Reingold, Stephen C, Cohen, Jeffrey A

“…The 2010 McDonald criteria for the diagnosis of multiple sclerosis are widely used in research and clinical practice. Scientific advances in the past 7 years…”
Get full text

Progressive patterns of neurological disability in multiple sclerosis and neuromyelitis optica spectrum disorders by Akaishi, Tetsuya, Takahashi, Toshiyuki, Misu, Tatsuro, Abe, Michiaki, Ishii, Tadashi, Fujimori, Juichi, Aoki, Masashi, Fujihara, Kazuo, Nakashima, Ichiro

“…The progressive patterns of neurological disability in multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) and the significance of…”
Get full text

Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations by Juryńczyk, Maciej, Jacob, Anu, Fujihara, Kazuo, Palace, Jacqueline

“…The field of central nervous system (CNS) inflammatory diseases has recently broadened to include a new condition associated with pathogenic serum antibodies…”
Get more information

Efficacy and Safety of Inebilizumab, an Anti-CD19 Monoclonal Antibody, for the Treatment of Neuromyelitis Optica Spectrum Disorder: Based on the N-MOmentum Trial by Fujihara, Kazuo, Sato, Hirokazu

“…Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune astrocytopathic disease of the central nervous system characterized by severe optic neuritis…”
Get more information

Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study by Takai, Yoshiki, Misu, Tatsuro, Kaneko, Kimihiko, Chihara, Norio, Narikawa, Koichi, Tsuchida, Satoko, Nishida, Hiroya, Komori, Takashi, Seki, Morinobu, Komatsu, Teppei, Nakamagoe, Kiyotaka, Ikeda, Toshimasa, Yoshida, Mari, Takahashi, Toshiyuki, Ono, Hirohiko, Nishiyama, Shuhei, Kuroda, Hiroshi, Nakashima, Ichiro, Suzuki, Hiroyoshi, Bradl, Monika, Lassmann, Hans, Fujihara, Kazuo, Aoki, Masashi

“…Conformation-sensitive antibodies against myelin oligodendrocyte glycoprotein (MOG) are detectable in patients with optic neuritis, myelitis, opticomyelitis,…”
Get full text

Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids by Matsumoto, Yuki, Kaneko, Kimihiko, Takahashi, Toshiyuki, Takai, Yoshiki, Namatame, Chihiro, Kuroda, Hiroshi, Misu, Tatsuro, Fujihara, Kazuo, Aoki, Masashi

“…Abstract The spectrum of MOG-IgG-associated disease (MOGAD) includes optic neuritis (ON), myelitis (MY), acute disseminated encephalomyelitis (ADEM), brainstem…”
Get full text

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders by Sato, Douglas Kazutoshi, Callegaro, Dagoberto, Lana-Peixoto, Marco Aurelio, Waters, Patrick J, Jorge, Frederico M. de Haidar, Takahashi, Toshiyuki, Nakashima, Ichiro, Apostolos-Pereira, Samira Luisa, Talim, Natalia, Simm, Renata Faria, Lino, Angelina Maria Martins, Misu, Tatsuro, Leite, Maria Isabel, Aoki, Masashi, Fujihara, Kazuo

“…OBJECTIVE:To evaluate clinical features among patients with neuromyelitis optica spectrum disorders (NMOSD) who have myelin oligodendrocyte glycoprotein (MOG)…”
Get full text

Impact of comorbid Sjögren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders by Akaishi, Tetsuya, Takahashi, Toshiyuki, Fujihara, Kazuo, Misu, Tatsuro, Fujimori, Juichi, Takai, Yoshiki, Nishiyama, Shuhei, Abe, Michiaki, Ishii, Tadashi, Aoki, Masashi, Nakashima, Ichiro

“…Background Neuromyelitis optica spectrum disorders (NMOSD) are autoimmune neurological diseases of the central nervous system, which are characterized by the…”
Get full text

Repeated follow-up of AQP4-IgG titer by cell-based assay in neuromyelitis optica spectrum disorders (NMOSD) by Akaishi, Tetsuya, Takahashi, Toshiyuki, Nakashima, Ichiro, Abe, Michiaki, Ishii, Tadashi, Aoki, Masashi, Fujihara, Kazuo

“…Neuromyelitis optica spectrum disorder (NMOSD) is characterized by the presence of serum anti-aquaporin 4 (AQP4) antibody. However, the significance of changes…”
Get full text

Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders by Palace, Jacqueline, Lin, Dan-Yu, Zeng, Donglin, Majed, Masoud, Elsone, Liene, Hamid, Shahd, Messina, Silvia, Misu, Tatsuro, Sagen, Jessica, Whittam, Daniel, Takai, Yoshiki, Leite, Maria Isabel, Weinshenker, Brian, Cabre, Philippe, Jacob, Anu, Nakashima, Ichiro, Fujihara, Kazuo, Pittock, Sean J

“…Using an international data set of 441 patients with AQP4-IgG positive NMOSD, and a collective history of almost 2000 attacks, Palace et al. apply mathematical…”
Get full text

CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications by Kaneko, Kimihiko, Sato, Douglas Kazutoshi, Nakashima, Ichiro, Ogawa, Ryo, Akaishi, Tetsuya, Takai, Yoshiki, Nishiyama, Shuhei, Takahashi, Toshiyuki, Misu, Tatsuro, Kuroda, Hiroshi, Tanaka, Satoru, Nomura, Kyoichi, Hashimoto, Yuji, Callegaro, Dagoberto, Steinman, Lawrence, Fujihara, Kazuo, Aoki, Masashi

“…ObjectiveTo evaluate cerebrospinal fluid (CSF) cytokine profiles in myelin oligodendrocyte glycoprotein IgG-positive (MOG-IgG+) disease in adult and paediatric…”
Get full text

Relapse activity in the chronic phase of anti-myelin-oligodendrocyte glycoprotein antibody-associated disease by Akaishi, Tetsuya, Misu, Tatsuro, Fujihara, Kazuo, Takahashi, Toshiyuki, Takai, Yoshiki, Nishiyama, Shuhei, Kaneko, Kimihiko, Fujimori, Juichi, Ishii, Tadashi, Aoki, Masashi, Nakashima, Ichiro

“…Objective The patterns of relapse and relapse-prevention strategies for anti-myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) are not…”
Get full text

Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications by Fujihara, Kazuo, Becker, Jefferson, Sato, Douglas Kazutoshi, Passos, Giordani Rodrigues Dos

“…Several animal and human studies have implicated CD4+ T helper 17 (Th17) cells and their downstream pathways in the pathogenesis of central nervous system…”
Get full text

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria by Polman, Chris H., Reingold, Stephen C., Banwell, Brenda, Clanet, Michel, Cohen, Jeffrey A., Filippi, Massimo, Fujihara, Kazuo, Havrdova, Eva, Hutchinson, Michael, Kappos, Ludwig, Lublin, Fred D., Montalban, Xavier, O'Connor, Paul, Sandberg-Wollheim, Magnhild, Thompson, Alan J., Waubant, Emmanuelle, Weinshenker, Brian, Wolinsky, Jerry S.

“…New evidence and consensus has led to further revision of the McDonald Criteria for diagnosis of multiple sclerosis. The use of imaging for demonstration of…”
Get full text